Late-breaking abstracts highlight treatment advances in CLL, myeloma, and moreNovember 22, 2017Hematologic MalignanciesMultiple Myeloma
Tailored approaches to relapsed/recalcitrant myeloma found within NCCN guidelinesOctober 12, 2017Multiple Myeloma
New antibodies, drugs for refractory and relapsed myeloma are effective in patients over 65September 20, 2017Multiple Myeloma
Differential Response to Carfilzomib Based on Initial Therapy With Bortezomib in Multiple MyelomaAugust 1, 2017Multiple Myeloma
Less lenalidomide may be more in frail elderly multiple myeloma patientsJuly 27, 2017Hematologic MalignanciesMultiple Myeloma
Four drugs better than three for myeloma inductionJuly 25, 2017Hematologic MalignanciesMultiple Myeloma
Novel CAR T cells drive high objective response rate in multiple myelomaJune 12, 2017Hematologic MalignanciesMultiple Myeloma
